- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about CA:CURA
Recent news which mentions CA:CURA
Curaleaf to ring opening bell at TSX to mark stock listing
December 13, 2023
From MarketWatch
Cannabis company Curaleaf draws downgrade to hold at Benchmark, while Wedbush sticks to outperform
May 19, 2023
From MarketWatch
Curaleaf wins renewal for New Jersey license after emergency regulatory commission meeting
April 17, 2023
From MarketWatch
Is the cannabis gold rush over? Moves by Curaleaf, Ayr, Akerna and other companies point to tough times.
January 30, 2023
From MarketWatch
Curaleaf cutting 10% of staff as it exits three U.S. states
January 26, 2023
From MarketWatch
From MarketWatch
From MarketWatch
Akanda pivots to German market as cannabis reform gains traction
August 30, 2022
From MarketWatch
From MarketWatch
Analyst slashes revenue outlook for Trulieve, Curaleaf, Canopy, Cronos as cannabis business takes a hit
August 12, 2022
From MarketWatch
From MarketWatch
From MarketWatch
Curaleaf narrows quarterly loss and tops $1 billion in annual revenue for the first time
March 04, 2022
From MarketWatch
Curaleaf moves to quash rumors that executives’ ties to Russia may lead to sanctions
February 28, 2022
From MarketWatch
Tilray expected to grow sales sequentially but remain in the red
January 06, 2022
From MarketWatch
Curaleaf gives back recent gains as its quarterly loss widens and it guides for 2021 revenue to be at the lower end of its range
November 09, 2021
From MarketWatch
Cannabis stocks rally on talk of M&A and latest moves toward possible reform of federal ban
November 08, 2021
From MarketWatch
From MarketWatch
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.